Literature DB >> 32056135

Do rapid emotional thermometers correlate with multidimensional validated structured questionnaires in low-risk prostate cancer?

Walker Wendell Laranja1, Thairo Alves Pereira1, Paulo Vitor Barreto Guimarães1, Marcos Tobias-Machado1, Vânia Aparecida Leandro-Merhi1, José Luis Braga de Aquino1, Leonardo Oliveira Reis2.   

Abstract

PURPOSE: To promptly identify mental suffering in low-risk prostate cancer (LRPC) patients, vulnerable to over- and undertreatment, we evaluated the correlation of rapid emotional thermometers (ET) with multidimensional validated structured questionnaires.
METHODS: At diagnosis, consecutive LRPC patients underwent five ET domains: emotional suffering, anxiety, depression (DT), revolt and need for help and multidimensional questionnaires: beck anxiety inventory (BAI), beck depression inventory (BDI), beck hopelessness scale, SF36 (physical functioning PF, role limitations due to physical health RP, bodily pain BP, general health perceptions GH, vitality VT, social functioning SF, role limitations due to emotional problems RE and general mental health MH), international index of erectile function and international prostate symptom score (IPSS).
RESULTS: Among 30 included patients, mean age 67.4 y (52-74), 20 days after the diagnosis (15-30), mean time to obtain ET 27 s (15-57) and all questionnaires 36.7 min (31-49), ETs showed moderate/strong Spearman correlation among themselves. DT domain displayed the best correlation to most of the multidimensional validated structured questionnaires: moderate to BDI, SF-36 (PF, GH, VT, SF, RE, MH) and IPSS and strong to BAI.
CONCLUSION: DT revealed the best correlation to validated structured questionnaires of diverse dimensions with clear potential for quick screening of patients with psychological suffering and in need of further evaluation and support.

Entities:  

Keywords:  Emotional; HRQoL; Prostate cancer; Questionnaire; Suffering; Thermometer

Year:  2020        PMID: 32056135     DOI: 10.1007/s11255-020-02399-w

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Validation of the Distress Thermometer, Impact Thermometer and combinations of these in screening for distress.

Authors:  Donald McLaren Baken; Cheryl Woolley
Journal:  Psychooncology       Date:  2011-03-02       Impact factor: 3.894

2.  The IPOS new International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care.

Authors:  Jimmie Holland; Maggie Watson; Jeff Dunn
Journal:  Psychooncology       Date:  2011-07       Impact factor: 3.894

3.  Screening for psychologic distress in ambulatory cancer patients.

Authors:  Paul B Jacobsen; Kristine A Donovan; Peter C Trask; Stewart B Fleishman; James Zabora; Frank Baker; Jimmie C Holland
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

4.  Relationship of depression to patient satisfaction: findings from the barriers to breast cancer study.

Authors:  Quynh-Uyen T Bui; Glenn V Ostir; Yong-Fang Kuo; Jean Freeman; James S Goodwin
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

5.  Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists.

Authors:  Alex J Mitchell; Stephen Kaar; Chris Coggan; Joanne Herdman
Journal:  Psychooncology       Date:  2008-03       Impact factor: 3.894

6.  Can the Distress Thermometer be improved by additional mood domains? Part I. Initial validation of the Emotion Thermometers tool.

Authors:  Alex J Mitchell; Elena A Baker-Glenn; Lorraine Granger; Paul Symonds
Journal:  Psychooncology       Date:  2010-02       Impact factor: 3.894

7.  Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach.

Authors:  M Keller; S Sommerfeldt; C Fischer; L Knight; M Riesbeck; B Löwe; C Herfarth; T Lehnert
Journal:  Ann Oncol       Date:  2004-08       Impact factor: 32.976

8.  The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

Authors:  David M Latini; Stacey L Hart; Sara J Knight; Janet E Cowan; Phillip L Ross; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

9.  Interview-based versus questionnaire-based quality of life outcomes before and after prostatectomy.

Authors:  Henk G van der Poel; Corinne Tillier; Willem M de Blok; Cenk Acar; Erik H A M van Muilekom; Roderick C N van den Bergh
Journal:  J Endourol       Date:  2013-08-09       Impact factor: 2.942

Review 10.  Screening for emotional distress in cancer patients: a systematic review of assessment instruments.

Authors:  Andrea Vodermaier; Wolfgang Linden; Christopher Siu
Journal:  J Natl Cancer Inst       Date:  2009-10-13       Impact factor: 13.506

View more
  1 in total

1.  Fasting and 24-h urine pH in patients with urolithiasis using potassium citrate.

Authors:  Isabela Bertanholi Leme da Silva; Carmen Petean Amaro; João Luiz Amaro; Natália Baraldi Cunha; Matheus Augusto Callegari; Hamilto Akihissa Yamamoto; Rodrigo Guerra; Juliany Gomes Quitzan; Leonardo O Reis; Paulo Roberto Kawano
Journal:  Am J Clin Exp Urol       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.